Our findings that the FINDRISC predicts changes in insulin secretion and insulin sensitivity gives evidence that this risk score reflects both major pathophysiological defects needed for the conversion to type 2 diabetes. This evidence concerns the gene INS and type 2 diabetes mellitus.